1.
Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). EJRDI [Internet]. 2023 Nov. 6 [cited 2026 Jan. 30];26:1-4. Available from: https://geniusjournals.org/index.php/ejrdi/article/view/5178